Showing results (41-50 of 171) with videos related to
Sort By:
Pageof 18
Biostatistics (Oxford, England)|June 2, 2025
Sensitivity analysis for the probability of benefit in randomized controlled trials with a binary treatment and a binary outcomeIuliana Ciocănea-Teodorescu, Erin E Gabriel, Arvid SjölanderEpidemiology (Cambridge, Mass.)|July 12, 2012
Sibling comparison designs: bias from non-shared confounders and measurement errorThomas Frisell, Sara Öberg, Ralf Kuja-Halkola, et al.The International Journal of Eating Disorders|November 18, 2020
Emotion dysregulation and suicidality in eating disordersMarianna Rania, Elin Monell, Arvid Sjölander, et al.Annals of Human Genetics|June 26, 2007
Fine mapping of disease genes using tagging SNPsArvid Sjölander, Ola Hössjer, Linda Werner Hartman, et al.Human Genetics|April 4, 2019
On the relationship between the heritability and the attributable fractionElisabeth Dahlqwist, Patrik K E Magnusson, Yudi Pawitan, et al.Rheumatology (Oxford, England)|February 23, 2023
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model applicationAndrei Barbulescu, Arvid Sjölander, Bénédicte Delcoigne, et al.American Journal of Epidemiology|March 17, 2021
Adjustment for Disease Severity in the Test-Negative Study DesignIuliana Ciocănea-Teodorescu, Martha Nason, Arvid Sjölander, et al.Biometrics|September 2, 2008
Sensitivity analysis for principal stratum direct effects, with an application to a study of physical activity and coronary heart diseaseArvid Sjölander, Keith Humphreys, Stijn Vansteelandt, et al.Biostatistics (Oxford, England)|September 2, 2022
Cross-direct effects in settings with two mediatorsErin E Gabriel, Arvid Sjölander, Dean Follmann, et al.British Journal of Cancer|January 23, 2023
Confirmatory prediction-driven RCTs in comparative effectiveness settings for cancer treatmentAdam Brand, Michael C Sachs, Arvid Sjölander, et al.Pageof 18